<DOC>
	<DOCNO>NCT00351676</DOCNO>
	<brief_summary>We , researcher , propose link clinical pharmacist internal medicine family medicine team provide pharmaceutical care patient assign team . The hypothesis team base approach , pharmacists act resource provide pharmacotherapeutic advice drug therapy decision make process promote optimal drug use identify resolve actual potential drug relate problem . This study design test hypothesis , assess impact intervention evidence base , quality drug therapy indicator , patient admit heart failure ( HF ) , chronic obstructive pulmonary disease ( COPD ) , community acquire pneumonia ( CAP ) , type 2 diabetes mellitus ( T2DM ) , stable coronary artery disease ( CAD ) .</brief_summary>
	<brief_title>Capturing Outcomes Clinical Activities Performed Rounding Pharmacist Practising Team Environment</brief_title>
	<detailed_description>The overall goal COLLABORATE study improve process care patient outcome optimize drug therapy via hospital pharmacy practice model integrate clinical pharmacist patient care team . The intervention consist clinical pharmacist assign patient care team purpose provide proactive clinical pharmacy service . The study pharmacist available normal office hour 5 day per week provide clarification patient 's medication history , identify resolve actual potential patient specific drug relate problems/issues , participate patient care round , provide drug information patient care team , provide patient education discharge medication counselling , provide physician and/or nursing staff education . The anticipated pharmacist patient ratio approximately 1:20 . Control patient receive usual care . Usual care consist reactive clinical pharmacy service ( i.e . drug related issue identify order receive , patient profile review ) provide ward base , team base , clinical pharmacist .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Consecutive patient &gt; 18 year age admit participate internal family medicine team 1 year study period eligible receive pharmacist intervention . For purpose data analysis , patient responsible primary diagnosis HF , COPD , CAP , T2DM , CAD include . Residence outside Capital Health catchment Admitted â‰¤ 2 day Palliative care Transferred another team</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>Drug Therapy</keyword>
	<keyword>Hospitals , Teaching</keyword>
	<keyword>Hospitals , Community</keyword>
	<keyword>Interprofessional relation</keyword>
	<keyword>Patient Care Team</keyword>
	<keyword>Pharmacists</keyword>
	<keyword>Pharmacy Service , Hospital</keyword>
	<keyword>Comparative Study</keyword>
	<keyword>Hospitalization</keyword>
</DOC>